The Hidden Cost of Old Healthcare Technology That Nobody Is Measuring
Every healthcare organisation has technology it knows it should replace. An EHR module that has not been updated since the original implementation. A billing system running on infrastructure that the vendor stopped supporting two years ago. A patient portal that was state of the art in 2014 and is functionally embarrassing in 2026.
These systems do not appear broken. They appear functional. And that appearance is why the cost they carry is almost never fully measured.
Technology debt in healthcare is the accumulated cost of running systems that are older, less capable, and more expensive to maintain than what current alternatives would provide. It is not a concept unique to healthcare — software development teams coined the term decades ago, but healthcare has accumulated it at a scale and with consequences that are distinctive to the industry.
The average health system carries between $50 million and $150 million in technology debt when the full cost is properly accounted for, according to Gartner's healthcare IT analysis. Most healthcare finance teams have never seen a number that large on any single line of their technology budget because technology debt does not show up as a line item. It is distributed invisibly across maintenance contracts, custom integration costs, workaround labour, missed capability, and security vulnerability.
What Technology Debt Actually Is
Technology debt is not the same as having old technology. Every organisation runs systems that are not the newest version of whatever the market offers. Technology debt is specifically the cost differential between what you are spending to maintain and work around an ageing system and what you would spend if you replaced it with a modern alternative.
It has two components.
The first is the direct cost of maintenance. Older systems cost more to keep running than newer ones. Vendor support contracts for legacy platforms are expensive and often come with significant limitations on what is covered. Custom integrations built years ago by contractors who are no longer engaged become fragile over time and expensive to repair when they break. Security patching for legacy systems is frequently more complex and costly than for modern platforms.
The second is the opportunity cost. This is harder to quantify and rarely attempted. A legacy system that does not support real-time data exchange prevents the organisation from deploying clinical decision support tools that require it. A billing system that cannot integrate with modern payer platforms creates manual reconciliation work that would not exist with a current alternative. A patient portal that cannot support intelligent outreach means that every proactive patient communication requires staff intervention.
The opportunity cost of technology debt in healthcare is enormous and largely invisible because the calculation requires comparing what the organisation is doing against what it could be doing if the technology were not the limiting factor.
How Healthcare Accumulated So Much of It
Healthcare technology debt did not accumulate through neglect or poor decision-making. It accumulated through a combination of factors that are genuinely difficult to manage.
The pace of regulatory change in healthcare means that technology investment cycles are frequently disrupted. A health system mid-way through an EHR migration may pause when a new interoperability regulation requires significant development resources. A security infrastructure modernisation may be deprioritised when a merger requires immediate attention to integration.
The complexity of healthcare technology environments makes replacement decisions expensive and risky. Replacing a core clinical system in a running hospital is not like replacing enterprise software in a typical commercial organisation. Clinical workflows are dependent on specific system behaviours in ways that are often undocumented. Interfaces between clinical systems are frequently custom and fragile. The cost and risk of replacement is real and significant.
And the capital allocation decisions in healthcare consistently favour clinical investment over technology investment when resources are constrained. This is understandable. Buying a new imaging system with a clear clinical benefit is easier to approve than replacing a billing platform to reduce integration complexity.
The result is that many healthcare organisations find themselves ten or fifteen years into a technology stack that was designed for a world that no longer exists, spending significant ongoing cost to maintain it, and unable to easily deploy the modern capabilities their clinical and operational teams need.
What Technology Debt Actually Costs
The maintenance cost component of technology debt is at least partially visible in most healthcare budgets, even if it is not labelled as debt. Vendor support contracts appear in IT budgets. Custom integration maintenance shows up in project costs.
What is almost never calculated is the operational cost of the workarounds that technology debt requires.
A clinical team working around a system that does not support a workflow they need develops manual processes. Those processes require time. That time has a labour cost. The labour cost of workarounds that exist solely because the technology does not support the workflow is technology debt expressed as payroll.
A finance team that cannot access real-time financial data because the financial system only produces monthly reports is spending decision-making capacity on outdated information. The cost of those sub-optimal decisions, the budget variances that could have been caught earlier, the revenue opportunities that were not identified in time, is technology debt expressed as missed financial performance.
Research from Deloitte's healthcare practice suggests that organisations with high technology debt spend an average of 15 percent more on operational workarounds than organisations that have systematically addressed their legacy technology environments. For a mid-sized health system with $500 million in operating expenses, that is $75 million of operational spend that is partly a function of technology architecture decisions made a decade ago.
Why Technology Debt Compounds
The insidious characteristic of technology debt is that it does not stay static. Like financial debt, it accumulates interest.
An integration built to connect two systems that were both installed in 2015 may function adequately when both systems are on their original versions. As one system is updated and the other is not, the integration becomes increasingly fragile. As the gap between versions widens, the cost of maintaining the integration increases and the risk of failure grows. At some point the integration fails in a way that is difficult and expensive to remediate.
The security dimension compounds particularly aggressively. A system that is not receiving security updates is accumulating vulnerability over time. The longer it runs without updates, the more known vulnerabilities it carries, and the more expensive the eventual remediation or replacement becomes.
And the opportunity cost compounds because the gap between what legacy systems can do and what modern alternatives can do continues to widen. An organisation that deferred replacing a billing system five years ago is now five years further behind the capabilities that modern revenue cycle automation provides.
A Strategic Approach to Addressing Technology Debt
Healthcare organisations that address technology debt effectively do not do so by attempting to replace everything at once. They do so by developing a clear picture of where the debt is, prioritising based on cost and risk, and executing replacement in a way that manages operational disruption.
The first step is an honest inventory. This means identifying every significant system in the technology environment, documenting the age of the installation and the version being run, quantifying the annual cost of maintenance and support, and estimating the operational workaround cost associated with each system's limitations.
Most healthcare organisations have never done this exercise at the level of detail it requires. The inventory itself is frequently the most valuable output of a technology audit, because it makes visible a cost that has previously been distributed and invisible.
The second step is prioritisation. Not every legacy system carries the same risk or cost. Systems with active security vulnerabilities and high clinical exposure should be prioritised regardless of replacement complexity. Systems whose limitations are generating significant operational workaround costs should be next. Systems that are old but stable and whose limitations are manageable can be addressed later.
The third step is realistic planning. Technology replacement in healthcare is expensive and disruptive. Organisations that acknowledge this and plan for it, budgeting adequately, sequencing implementations to manage operational impact, investing in the change management that makes adoption successful, achieve replacement at lower total cost than organisations that underestimate the complexity and find themselves mid-implementation without sufficient resources to complete it.
Technology debt does not resolve itself. It accumulates, compounds, and eventually forces a crisis that is more expensive to address than planned remediation would have been.
The organisations addressing it proactively are spending more in the short term and significantly less over the decade.
Comments